Evidence map›Paper›PMID 42199962›Full record

ReviewFrontiers in neurology

Ferrets as a model for investigating the impact of chemical agents on cerebral cortical sulcogyrogenesis.

Kazuhiko Sawada

Abstract readReview
In one paragraph

Review in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kazuhiko SawadaDepartment of Nutrition, Faculty of Medical and Health Sciences, Tsukuba International University, Tsuchiura, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gyrencephalic features of the cerebral cortex have been documented in many mammals, exhibiting unique species-related patterns, and are disturbed in individuals with neurodevelopmental and/or psychiatric disorders, including autism spectrum disorder. This mini-review article provides an overview of a series of studies that have investigated sulcogyral developmental alteration as the outcome of two chemical agents with the potential to cause autism spectrum disorder, valproic acid (VPA) and lipopolysaccharide (LPS), using ferrets, which are gyrencephalic animals. Ferret pups received an injection of VPA (200 μg/g body weight) or LPS (500 μg/g of body weight) at 6 and 7 days of postnatal ages. VPA acts on the subventricular zone progenitors, including basal radial glia, to promote their differentiative division, resulting in shallow sulcal infolding in the rostrovental and medial cortices, while enhancing sulcal infolding in the dorsolateral cortex. In contrast, the apoptosis of cortical neurons derived from postproliferative subventricular zone progenitors in neonatally LPS-exposed ferrets may be involved in an anterior shift of the primary sulci located on the medial and dorsolateral cortices. These two agents affect subventricular zone progenitors differently, leading to distinct gyrification abnormality patterns. These findings suggest that the ferret is an advantageous animal model for elucidating the pathogenesis of neurodevelopmental and/or psychiatric disorders in terms of gyrification abnormalities raised by chemical agents.

Indexed as

ferretgyrificationgyrusLPSneurogenesissubventricular zonesulcusVPA

Identifiers

PMID42199962
PMCPMC13199045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.